Computer Aided Detection (CAD): Market Research Report

December 2014 | 115 pages | ID: C0C2A2D9B1FEN
Global Industry Analysts, Inc

Abstracts

This report analyzes the US and European markets for Computer Aided Detection (CAD) in US$ Thousands by the following Application Segments - Breast, Chest, and Others. The US market is also analysed in Number of Units for the above Application Segments. The report also provides a consolidated, single-segment volume analysis for the European market. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 29 companies including many key and niche players such as -

• EDDA Technology, Inc.
• Hologic, Inc.
• iCAD, Inc.
• Invivo Corp.
• Merge Healthcare, Inc.

Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study

II. A US AND EUROPEAN MARKET REPORT

1. OUTLOOK

Computer Aided Detection - Offering “Second Look” for Radiology Analysis
The Need for Early Disease Diagnosis and the Role of CAD

Table 1. Global Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)

Market Highlights
Major Drivers & Restraints
Breast CAD to Hold its Forte in the CAD Market
Recession in Retrospect and the Road Ahead
Improving Healthcare Expenditure to Foster Growth

Table 2. Per-Capita Healthcare Expenditure in US$ for Select Regions: 2014 (includes corresponding Graph/Chart)

Table 3. Healthcare Spending as a Percentage of GDP in Select Developing Countries (2014E) (includes corresponding Graph/Chart)

Table 4. Healthcare Spending as a Percentage of GDP in Select Developed Countries for 2004, 2008 & 2014E (includes corresponding Graph/Chart)

Table 5. Top 20 Countries with the Highest Healthcare Spending as a Percentage of GDP: 2014E (includes corresponding Graph/Chart)

2. MARKET OVERVIEW & TRENDS

From “Second Reader” to “First Reader” Use - the Unconquered Avenue of CAD Systems
CAD Use Rises despite Controversies
Replacements to Fuel Market Growth
High Dependence on Related Modality Continues
Market Calls for Higher Efficiencies in CAD
Product Developments Underway to Expand Utility
Information Provision - A Key Feature under Development for Enhanced Efficiency
Research finds Interactive Use of CAD More Efficient
Rising Incidence of Cancer - A Major Market Driver
Cancer Prone Sites based on Age
World Cancer Statistics - Incidence and Mortality Data

Table 6. World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported in Thousands for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)

Table 7. World Cancer Mortality by Geographic Region and Gender (2012): Number of Cancer- Related Deaths in Thousands for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)

Table 8. Global Incidence of Common Cancers in Men (2012): Number of New Cases Reported in Thousands for Lung & Bronchus, Prostate, Colorectal and Liver Cancers (includes corresponding Graph/Chart)

Table 9. Global Incidence of Common Cancers in Women (2012): Number of New Cases Reported in Thousands for Breast, Colorectal, Lung & Bronchus and Liver Cancers (includes corresponding Graph/Chart)

Table 10. Global Cancer Mortality in Men for Select Cancers (2012): Number of Deaths in Thousands for Lung & Bronchus, Liver, Colorectal and Prostate Cancers (includes corresponding Graph/Chart)

Table 11. Global Cancer Mortality in Women for Select Cancers (2012): Number of Deaths in Thousands for Breast, Lung & Bronchus, Colorectal and Liver (includes corresponding Graph/Chart)

Table 12. World Breast Cancer Statistics (2012): Top 20 Countries with Highest Breast Cancer Rates (includes corresponding Graph/Chart)

3. COMPETITION

iCAD - A Leading Independent Player in the Mammography CAD Segment

4. APPLICATIONS OF CAD

Present Applications of CAD
What Lies Ahead at the Application Front?
CAD in Breast Cancer
CAD Simplifies Breast MRI Image Analysis; Tremendous Scope for Adoption Ahead
Breast MRI - Lagging behind Mammography in Cancer Detection
CAD Solutions for Breast Cancer
SecondLook Digital (iCAD)
R2 ImageChecker (Hologic, Inc. )
SpectraLook CAD Solution (iCAD)
DynaCAD Breast (Invivo)
CADstream Breast MRI Application (Merge Healthcare)
List of Select Approved CAD Solutions for Breast MRI
CAD in Prostate Cancer
CAD in Lung Cancer
The Background
An Overview of CAD Solutions for Lung Cancer Detection
IQQA (EDDA Technology)
ClearRead +Detect (formerly OnGuard) (Riverain Technologies)
xLNA (Philips)
syngo CAD Solutions (Siemens)
CAD in Liver Cancer
CAD Solutions for Liver Cancer Detection
CADstream (Merge Healthcare)
IQQA (EDDA Technology)
CAD in the Detection of Prostate Cancer
Available CAD Solutions for Prostate Cancer
CAD in the Detection of Colon Cancer
CAD in Cardiology
Increasing Need for CAD in Cardiology

Table 13. Cardiovascular Disease Incidence in the US by Gender & Age Group (per 1,000 Adults) (includes corresponding Graph/Chart)

Automatic Workflow Integration Fuels Demand for Cardiac CAD
Significant Hurdles Exist for CAD in Cardiology

5. REGIONAL PERSPECTIVE

5A. THE UNITED STATES

A. Market Analysis
Current & Future Analysis
Challenges in Evaluation Dents Approvals of New CAD Systems
Final Guidance Documents on CAD offers Respite to Industry Players
CAD Devices, as Defined by the FDA
Guidance on 510(k) Application
FDA’s FFDM Reclassification to Benefit CAD Market
Competition

Table 14. The US Mammography CAD Market by Leading Player: 2014 (includes corresponding Graph/Chart)

Select FDA Approved CAD Software: 2001-2013
Ageing Demographics: A Key Market Driver

Table 15. North American Elderly Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)

Rising Cancer Incidence, and the Need for Early Detection Propel Market Growth

Table 16. New Cancer Cases in the US by State: 2014

Table 17. New Cancer Cases in the US by Gender and Affected Site: 2014

Table 18. Cancer Related Deaths in the US by Gender and Body Site: 2014

Table 19. Cancer Mortality in the US by Site for Male and Female Populations (2013): Breakdown of Number of Deaths for Breast, Lung & Bronchus, Colon & Rectum, Liver & Bile Duct, Prostate and Other Cancers (includes corresponding Graph/Chart)

CAD to Gain from Rapid Growth in CTC Volumes
Physicians’ Reluctance to Follow USPSTF - A Shot in the Arm for CAD Manufacturers
Mammography and Breast MRI, and CAD Reimbursement in the US
CMS Coverage for Screening and Diagnostic Mammography and Breast MRI - A Review

Table 20. Medicare Reimbursement Codes and Allowable Rates for CAD in Mammography: 2012-2014

Low and Spotty Reimbursement Mars CAD in Prostate Cancer Detection
No Separate Codes for CAD in Prostate MRI
B. Market Analytics
Value Analytics

Table 21. The US Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Breast, Chest and Other CAD Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)

Table 22. The US Historic Review for Computer Aided Detection (CAD) by Application - Breast, Chest and Other CAD Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2012 (includes corresponding Graph/Chart)

Table 23. The US 14-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Dollar Sales for Breast, Chest and Other CAD Markets for Years 2007, 2014 and 2020 (includes corresponding Graph/Chart)

Volume Analytics

Table 24. The US Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Breast, Chest and Other CAD Markets Independently Analyzed with Annual Sales Figures in Units for Years 2013 through 2020 (includes corresponding Graph/Chart)

Table 25. The US Historic Review for Computer Aided Detection (CAD) by Application - Breast, Chest and Other CAD Markets Independently Analyzed with Annual Sales Figures in Units for Years 2007 through 2012 (includes corresponding Graph/Chart)

Table 26. The US 14-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Unit Sales for Breast, Chest and Other CAD Markets for Years 2007, 2014 and 2020 (includes corresponding Graph/Chart)

5B. EUROPE

A. Market Analysis
Economic Woes Dampen European CAD Market Prospects
Long-Term Prospects Appear Brighter
Breast CAD Dominates, Other Applications to Witness Fastest Growth
Rising Incidence of Cancer

Table 27. European Cancer Incidence by Geographic Region (2012): Number of New Cancer Cases Reported in Thousands for Western Europe, Northern Europe, Southern Europe, and Central & Eastern Europe (includes corresponding Graph/Chart)

Table 28. Cancer Incidence in Western Europe by Site (2012): Number of New Cancer Cases Reported in Thousands for Prostate, Breast, Colorectal, Lung and Other Cancers (includes corresponding Graph/Chart)

Table 29. Cancer Incidence in Northern Europe by Site (2012): Number of New Cancer Cases Reported in Thousands for Breast, Prostate, Colorectal, Lung and Other Cancers (includes corresponding Graph/Chart)

Table 30. Cancer Incidence in Southern Europe by Site (2012): Number of New Cancer Cases Reported in Thousands for Colorectal, Breast, Lung, Prostate and Other Cancers (includes corresponding Graph/Chart)

Table 31. Cancer Incidence in Central and Eastern Europe by Site (2012): Number of New Cancer Cases Reported in Thousands for Lung, Colorectal, Breast, Stomach and Other Cancers (includes corresponding Graph/Chart)

Ageing Population Boosts Demand for Computer Aided Detection

Table 32. European Country-wise Statistics of 60+ Population as % of Total Population: 2013 (includes corresponding Graph/Chart)

B. Market Analytics
Value Analytics

Table 33. European Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Breast, Chest and Other CAD Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)

Table 34. European Historic Review for Computer Aided Detection (CAD) by Application - Breast, Chest and Other CAD Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2012 (includes corresponding Graph/Chart)

Table 35. European 14-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Dollar Sales for Breast, Chest and Other CAD Markets for Years 2007, 2014 and 2020 (includes corresponding Graph/Chart)

Volume Analytics

Table 36. European Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) Market Analyzed with Annual Sales Figures in Units for Years 2013 through 2020 (includes corresponding Graph/Chart)

Table 37. European Historic Review for Computer Aided Detection (CAD) Market Analyzed with Annual Sales Figures in Units for Years 2007 through 2012 (includes corresponding Graph/Chart)

6. PRODUCT OVERVIEW

CAD - An Introduction
A Brief History of CAD
Methodology
Sensitivity / Specificity
Absolute Detection Rate
Applications of Computer-Aided Detection
Breast Cancer
Lung Cancer (Bronchial Carcinoma)
Evolution of Computer-Aided Detection for Mammography
CAD Technology - Working Operation
Existing Limitations of CAD

7. PRODUCT INNOVATIONS/INTRODUCTIONS

VuCOMP Obtains Market Clearance for M-Vu CAD and M-Vu Breast Density in Turkey
VuCOMP Receives US FDA Approval for M-Vu CAD for Mammography Version 3.
iCAD Obtains FDA Clearance for Mammography CAD Platform
VuCOMP Receives Premarket Approval from FDA for M-Vu Film Mammography CAD
iCAD Introduces Advanced Mammography CAD System
Parascript Unveils Updated AccuDetect CAD Technology

8. RECENT INDUSTRY ACTIVITY

iCAD Expands Existing Partnership with Volpara Solutions
Salient Imaging Takes Over Medipattern
Real Time Tomography Inks Licensing Agreement with im3D
iCAD and Invivo Ink Agreement
Planmed and Three Palm Software Ink Partnership Agreement
Sectra Signs Agreement with Merge Healthcare

9. FOCUS ON SELECT PLAYERS

EDDA Technology, Inc. (US)
Hologic, Inc. (US)
iCAD, Inc. (US)
Invivo Corp. (US)
Merge Healthcare, Inc. (US)
Riverain Technologies (US)
Salient Imaging, Inc. (US)
Siemens Healthcare (Germany)
VuCOMP Inc. (US)

III. COMPETITIVE LANDSCAPE

Total Companies Profiled: 29 (including Divisions/Subsidiaries - 31)
The United States (21)
Japan (1)
Europe (8)
  Germany (2)
  Italy (1)
  Spain (1)
  Rest of Europe (4)
Asia-Pacific (Excluding Japan) (1)